Year of investment
MarraBio is developing a platform technology to produce engineered multimeric proteins that mimic complex molecules such as human growth factors and extracellular matrix proteins. The Company’s core technology is used to develop products for a pipeline of applications ranging from cell culture reagents for research purposes, to low-cost growth factors for cultivated meat production.
CPI value creation
MarraBio and CPI are collaborating on the development of analytical methods which will allow for a greater level of product characterisation. This method development will enable an increased level of productivity in their production process and ensure compliance with the relevant quality control systems. Alongside this analytical method development, the collaboration will provide a further understanding around the required regulatory requirements of the food industry.